www.hivandhepatitis.com

Back HCV Disease Progression

AASLD 2017: Curing Hepatitis C with DAAs Reduces Liver Cancer Risk

Details
Category: Liver Cancer/HCC
Published on Tuesday, 31 October 2017 00:00
Written by Liz Highleyman
  • Print

People who achieved a sustained virological response to hepatitis C treatment lowered their risk of hepatocellular carcinoma by around 70%, regardless of whether they were treated with new direct-acting antivirals (DAAs) or older interferon-based therapy, according to study results presented at the 2017 AASLD Liver Meeting last week in Washington, DC.

alt

 

Read more:

More Articles...

  1. EASL 2017: Hepatitis C Treatment Allows 1 in 4 to Come Off Liver Transplant Waiting List
  2. EASL 2017: Direct-Acting Antivirals for Hepatitis C Not Linked to Higher Liver Cancer Risk
  3. CROI 2017: Are HIV/HCV Coinfected People Cured with DAAs at Increased Risk for Liver Cancer?
  4. AASLD 2016: Is DAA Treatment for Hepatitis C Reducing the Need for Liver Transplants?
  5. AASLD 2016: Curing Hepatitis C Reduces Liver-Related Complications and Death

Subcategories

Copyright © 2023 www.hivandhepatitis.com. All Rights Reserved. Designed by JoomlArt.com. Joomla! is Free Software released under the GNU General Public License.

Bread and Roses Web DesignWeb Design and Development by Bread and Roses Web Design